Particle3D
3D printed fully-resorbable bone implants that disappear as patient's bone regrows
- CEO / Founder
- Thea Wulff Olesen
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $10.2M
- Latest Round
- Series A
- Key Investors
- Pre SEED Ventures, West Hill Capital, Asimov Ventures, Danish angel investors
Technology & Products
Key Products
P3D Scaffolds (research), custom bone implants, resorbable biomaterial technology
Technological Advantage
Patented tricalcium phosphate (TCP) bioink that stimulates natural bone growth
Differentiation
Value Proposition
Patient-specific bone implants that are fully absorbed as natural bone regrows
How They Differentiate
Fully resorbable implants vs permanent metal/plastic implants
Market & Competition
Target Customers
Hospitals, orthopedic surgeons, craniomaxillofacial surgeons
Industry Verticals
Medical, Healthcare, Orthopedics, Research
Competitors
Materialise Medical, Mimetis, Xilloc
Growth & Milestones
Growth Metrics
Launched P3D Scaffolds research products, preparing human implant launch
Major Milestones
2017: Founded as spinout from University of Southern Denmark, 2018: DKK 5.1M from Pre SEED Ventures, £2.5M from West Hill Capital, P3D Scaffolds launch, Jan 2022: Rebranded to Ossiform, Oct 2022: £6M Series A from West Hill Capital, Feb 2026: Accepted into ABHI 2026 U.S. Accelerator Program
Notable Customers
Research institutions, hospitals